论文部分内容阅读
目的观察异丙托溴铵治疗婴幼儿重症喘憋性肺炎临床疗效。方法 200例婴幼儿重症喘憋性肺炎患者随机分为两组,对照组给予常规抗感染、镇静、吸氧、祛痰等治疗,同时给予硫酸沙丁胺醇雾化溶液和吸入用布地奈德混悬液置压缩泵雾化吸入;观察组在对照组基础上加用异丙托溴铵雾化。结果加用异丙托溴铵治疗组有效排痰时间、憋喘缓解时间、痰鸣音消失时间、平均住院日两组比较差异有统计学意义(P<0.01)。结论异丙托溴铵雾化吸入治疗婴幼儿喘憋性肺炎疗效可靠,与沙丁胺醇合用可协同增强疗效,更起着相辅相成的互补作用,值得临床推广应用。
Objective To observe the clinical efficacy of ipratropium bromide in the treatment of infantile severe asthmatic pneumonia. Methods 200 infants and young children with severe asthmatic pneumonia were randomly divided into two groups. Patients in the control group were given routine anti-infective, sedative, oxygen and expectorant treatment. Salbutamol sulphate nebulized solution and inhaled budesonide suspension Set compression pump inhalation; observation group in the control group plus ipratropium bromide atomization. Results Plus ipratropium bromide treatment group effective timing of sputum discharge, time to wait for the release of phlegm, disappearance of phlegm, the average length of stay was significantly different between the two groups (P <0.01). Conclusions Ipratropium bromide inhalation is effective in treating asthmatic pneumonia in infants and young children. Combined with albuterol can enhance the curative effect and play a complementary role, which is worthy of clinical application.